Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Mechanisms of the therapeutic effect of bemitil in neuromuscular diseases

Lobzin, V.S.; Saĭkova, L.A.; Chukhlovina, M.L.; Pustozerov, V.G.

Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(9): 22-24

1991

ISSN/ISBN: 0044-4588
PMID: 1664607
Document Number: 697
Studies into the mechanism of the therapeutic action of bemitil were carried out in 21 patients with neuromuscular diseases. Measurements of lipid peroxidation and permeability of the erythrocytic membranes demonstrated the drug to influence carbohydrate and lipid metabolism, lipid peroxidation, and permeability of the cellular membranes. It is recommended that bemitil be used for the treatment of neuromuscular diseases.

Document emailed within 1 workday
Secure & encrypted payments

Mechanisms of the therapeutic effect of bemitil in neuromuscular diseases

Eguchi, T.; Tezuka, T.; Miyoshi, S.; Yamanashi, Y. 2017: Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach Clinical Calcium 27(3): 413-419
Lewis, N.J. 1985: The design and development of therapeutic agents for neuromuscular diseases Progress in Clinical and Biological Research 197: 105-110
Boĭko, S.S.; Zherdev, V.P.; Neznamov, G.G. 1991: The role of bemitil pharmacokinetics in realizing its therapeutic efficacy Farmakologiia i Toksikologiia 54(2): 64-66
Obrosov, A.N. 1970: Main mechanisms of therapeutic action of health resort and physiotherapeutic factors in cardiovascular diseases Vestnik Akademii Meditsinskikh Nauk SSSR 25(4): 79-85
Mikhałlov, I.B.; Guzeva, V.I.; Sharf, M.Ia.; Basharina, O.B.; Chałka, N.A. 1997: The effect of bemitil on the parameters of lipid peroxidation and nitrogen metabolism in epilepsy in children Eksperimental'naia i Klinicheskaia Farmakologiia 60(3): 20-22
Pragina, L.L.; Tushmalova, N.A.; Inozemtsev, A.N.; Smirnov, A.V. 1999: The effect of bemitil on conditioned-reflex memory in normal rats and under stress exposures Eksperimental'naia i Klinicheskaia Farmakologiia 62(4): 9-10
Song, Y.-y.; Li, Y.; Zhang, H.-q. 2010: Therapeutic effect of syringin on adjuvant arthritis in rats and its mechanisms Yao Xue Xue Bao 45(8): 1006-1011
Kondratenko, I.N.; Minaeva, E.I. 1987: Hypotensive effect of scleroplasty as 1 of the pathogenetic mechanisms of its therapeutic action in progressive myopia Oftalmologicheskii Zhurnal 1: 34-36
Merkulov, I.A.; Merkulova, D.M.; Kryzhanovskiĭ, G.N. 2006: Therapeutic effect of dexalgin on disturbances of vertebrogenic and nonvertebrogenic mechanisms in back pain Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 106(5): 20-24
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Sumarokov, A.B. 1990: Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics Kardiologiia 30(1): 95-100
Fagoaga, J.; Girabent-Farres, M.; Bagur-Calafat, C. 2017: Translation and validation of the Individualised Neuromuscular Quality of Life scale for the Spanish population: quality of life assessment for persons with neuromuscular diseases Revista de Neurologia 64(5): 194-200
Girabent-Farres, M.; Monne-Guasch, L.; Bagur-Calafat, C.; Fagoaga, J. 2018: Spanish translation and validation of the neuromuscular module of the Pediatric Quality of Life Inventory (PedsQL): evaluation of the quality of life perceived by the parents of 2-4-year-old children with neuromuscular diseases Revista de Neurologia 66(3): 81-88
Ma, J.; Peng, A.; Lin, S. 1998: Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure Chinese Medical Journal 111(1): 17-23
Hemsworth, B.A.; Cholakis, J.M. 1972: Mechanisms of action of a hemicholinium analogue at the neuromuscular junction Journal of Pharmacy and Pharmacology 24: Suppl: 147p
Brănişteanu, D.D.; Sauciuc, A.; Proca, B.; Fuică, A.; Gogescu, G. 1982: Mechanisms of the neuromuscular blocking activity of the aminoglycoside antibiotic streptomycin Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 86(2): 287-294
Acarín, N. 1983: What therapeutic value does differential diagnosis have for neuromuscular patients? Medicina Clinica 81(5): 209-211
Fiegel, G. 1973: Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases Zeitschrift für Allgemeinmedizin 49(12): 592-594
Lau, J.Y. 1998: Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-inducedliver diseases American Journal of Physiology 275(6): G1217-G1220
Hayashi, K.; Itoh, H. 2015: Therapeutic effect of RAS inhibitors on epigenetic changes in life-style related diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 73(11): 1933-1938
Tsarfis, P.G. 1976: Therapeutic effect of radon baths of different concentrations in inflammatory and dystrophic diseases Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 1-7